//
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Mechanical circulatory support devices in advanced heart failure: 2020 and beyond
Antithrombotics From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5)
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions